-
World Aspergillosis Day 2025 Date: Know Aim and Significance of the Day That Raise Awareness About Aspergillosis Caused by the Aspergillus Fungus
01 Feb 2025 07:30 GMT
… global event.
World Aspergillosis Day 2025 Date
World Aspergillosis Day 2025 will … , February 1.
World Aspergillosis Day Significance World Aspergillosis Day serves as an … people about the condition. World Aspergillosis Day: Causes, Symptoms, Treatment and …
-
Coexistence of Asymptomatic Allergic Bronchopulmonary Aspergillosis and Active Pulmonary Tuberculosis: Case Report
21 Jan 2025 18:10 GMT
… bronchiectasis and chronic pulmonary aspergillosis, collectively termed post- … case of allergic bronchopulmonary aspergillosis following active pulmonary tuberculosis … Chhabra S. Allergic bronchopulmonary aspergillosis without asthma complicating pulmonary …
-
Assam cha bagano kam ka•giparango skanggipa chronic pulmonary aspergillosis (CPA) dongani sakkiko man•a
13 Jan 2025 12:03 GMT
… kam ka•giparango chronic pulmonary aspergillosis (CPA) dongani skanggipa sakkiko man …
-
Clinical Relevance of Elevated Serum Carcinoembryonic Antigen in Allergic Bronchopulmonary Aspergillosis/Mycosis: A Multicenter Retrospective Study
24 Dec 2024 16:52 GMT
… : ABPA, allergic bronchopulmonary aspergillosis; ABPM, allergic bronchopulmonary … : ABPA, allergic bronchopulmonary aspergillosis; ABPM, allergic bronchopulmonary …
Abbreviations
ABPA, Allergic bronchopulmonary aspergillosis; A. fumigatus, Aspergillus …
-
The Effect of Rifapentine and Rifampicin on Serum Voriconazole Levels Persist for 5 Days and 7 Days or More After Discontinuation in Tuberculosis Patients with Chronic Pulmonary Aspergillosis
08 Jul 2024 08:07 GMT
… patients with chronic pulmonary aspergillosis. These patients underwent a … patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial … pulmonary tuberculosis and invasive aspergillosis infection in an immunocompetent host …
-
Systemic Aspergillosis and Systemic Candidiasis Market to Reach $8.63 Billion by 2028
03 Jul 2024 16:15 GMT
… Application: Allergic Bronchopulmonary Aspergillosis (ABPA), Chronic Pulmonary Aspergillosis (CPA), Gastrointestinal … therapeutics-global-market-report
Aspergillosis Treatment Global Market … /report/aspergillosis-treatment-global-market-report
…
-
Global Systemic Aspergillosis and Systemic Candidiasis Analysis Report 2024-2030 with Analyst Recommendations - Focus on Personalized Medicine & Penetrating Developing Markets - ResearchAndMarkets.com
29 May 2024 13:03 GMT
… , such as invasive pulmonary aspergillosis or fungal endocarditis, surgical … therapy.
The Global Systemic Aspergillosis and Systemic Candidiasis Market experiences … , and patients.
Global Systemic Aspergillosis and Systemic Candidiasis Market Insights …
-
Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China
20 May 2024 08:55 GMT
… Thompson GR 3rd, Patterson TF. Aspergillosis: epidemiology, diagnosis, and treatment. … patients with invasive pulmonary aspergillosis and respiratory tract aspergillus … al. Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus …
-
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
12 Mar 2024 15:06 GMT
… ) for the treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM …
-
SCYNEXIS, Inc. Presents Preclinical Data on Second Generation Fungerp SCY-247 Against Mucormycosis At the 11Th Advances Against Aspergillosis and Mucormycosis Conference
30 Jan 2024 02:51 GMT
SCYNEXIS, Inc. announced the presentation of preclinical efficacy data on its second generation fungerp candidate SCY-247. Mucormycosis is a life-threatening fungal infection with an associated mortality that ranges from 46% to 96%, most commonly affecting …
About
© 1995-2025